Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
This important study, called a Phase 3 clinical trial, is looking for people with schizophrenia to test a new medication called KarXT. The main goal is to find out if KarXT can help prevent the symptoms of schizophrenia from returning, or relapsing. Participants will either receive KarXT or a placebo (a dummy pill with no active medicine) to see how well it works and if it's safe. This type of research is crucial for developing new and better treatments to help people manage their condition. All participants will be closely monitored by a medical team.
Auf einen Blick
Worum geht es in dieser Studie?
This research study is focused on improving treatments for schizophrenia, a long-term mental health condition that affects how a person thinks, feels, and behaves. The study is particularly interested in preventing relapses, which is when symptoms return or get worse after a period of improvement. Preventing relapses is a major goal in managing schizophrenia, as it can significantly impact a person's life and well-being.
The new medicine being tested is called KarXT. Researchers want to compare it to a 'placebo', which is a treatment that looks like the real medicine but contains no active ingredients. This comparison helps scientists understand if KarXT is truly effective and safe. By taking part in such a study, you could contribute to medical knowledge and potentially help others with schizophrenia in the future.
This is a 'Phase 3' study, meaning it's one of the final steps before a new medicine might be considered for general use. These studies are vital for making sure new treatments are both safe and work well for a large number of people before they become widely available.
Wichtige Erkenntnisse
- This study evaluates KarXT, a new medicine for schizophrenia.
- It aims to prevent symptoms from coming back (relapse prevention).
- It's a Phase 3 study, a late stage before potential general use.
- Participants will receive either KarXT or a placebo.
- Close medical monitoring and regular visits are required.
- Die Teilnahme ist freiwillig, und Sie können jederzeit zurücktreten.
Wer könnte berechtigt sein?
To join this study, you need to be an adult between 18 and 65 years old and have been diagnosed with schizophrenia for at least a year. You should have had a hospital stay for schizophrenia sometime in the last year, and currently be experiencing some symptoms, but not severely unwell or in a first-time episode.
There are also some requirements about your current health, such as your body mass index (BMI). You cannot have other significant mental health conditions diagnosed recently, or be at risk of suicidal thoughts. If you've previously had trouble responding to schizophrenia medications or had very long hospital stays recently, you might not be suitable for this study.
The medical team will carefully check all these points to make sure the study is a good and safe fit for everyone involved. They will use specific questionnaires and assessments, like one called PANSS, to confirm you meet the criteria.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie zwischen 18 und 65 Jahre alt?
- Have you been diagnosed with schizophrenia for at least a year?
- Have you been hospitalised for schizophrenia in the last year?
- Do you currently have some schizophrenia symptoms?
- Do you have a Body Mass Index (BMI) between 18 and 40?
- Have you not had a recent diagnosis of other major mental health conditions?
Was beinhaltet die Teilnahme?
If you decide to take part, you'll be randomly assigned to either receive the new medicine, KarXT, or a placebo (a dummy pill). You won't know which one you're getting, and neither will your study doctor, until the study is over. You'll need to attend regular appointments at the study clinic where you'll have check-ups, assessments, and receive your study medication. These appointments will involve talking about your symptoms, having physical health checks, and possibly blood tests.
The medical team will closely monitor your health and any changes you experience throughout the study. The exact number of visits and the full duration of your participation will be fully explained to you before you make any decisions. There will also be follow-up calls or visits after you stop taking the study medication to see how you are doing.
Potenzielle Risiken und Vorteile
Locations (59)
- Pillar Clinical Research - BentonvilleVerifizierte PostleitzahlBentonville, United States· Rekrutierung
- Pillar Clinical Research- Little RockVerifizierte PostleitzahlLittle Rock, Vereinigte Staaten· Rekrutierung
- Local Institution - 0021Verifizierte PostleitzahlLittle Rock, Vereinigte Staaten· Noch nicht rekrutiert
- Local Institution - 0153Verifizierte PostleitzahlRogers, United States· Noch nicht rekrutiert
- Local Institution - 0190Verifizierte PostleitzahlAnaheim, Vereinigte Staaten· Noch nicht rekrutiert
- Local Institution - 0040Verifizierte PostleitzahlBellflower, Vereinigte Staaten· Noch nicht rekrutiert
- Local Institution - 0188Verifizierte PostleitzahlChino, United States· Noch nicht rekrutiert
- Local Institution - 0032Verifizierte PostleitzahlCulver City, United States· Noch nicht rekrutiert
- Local Institution - 0037Verifizierte PostleitzahlGarden Grove, United States· Noch nicht rekrutiert
- Local Institution - 0068Verifizierte PostleitzahlLa Habra, United States· Noch nicht rekrutiert
- Local Institution - 0128Verifizierte PostleitzahlLemon Grove, United States· Noch nicht rekrutiert
- Local Institution - 0187Verifizierte PostleitzahlMontclair, United States· Noch nicht rekrutiert
Häufige Fragen
What is KarXT?
KarXT is a new medicine being tested to see if it can help prevent symptoms of schizophrenia from returning.
Was ist ein Placebo?
A placebo is a 'dummy pill' that looks like the real medicine but doesn't contain any active ingredients. It's used to compare against the new medicine.
Werde ich wissen, ob ich das echte Medikament bekomme?
No, neither you nor your study doctor will know if you're receiving KarXT or the placebo. This helps ensure the study results are fair and unbiased.
Wie lange werde ich an der Studie teilnehmen?
The full duration of your participation will be explained by the study team, including how long you'll take the medicine and how many follow-up visits there will be.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes, you are free to leave the study at any time, for any reason, without it affecting your regular medical care.
Wie Sie mehr erfahren können
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.